CH Innovations invests in early-stage companies developing innovative, evidence-based solutions to improve child health, supporting the translation of pediatric research into real-world impact.
Funder: Charles H. Hood Foundation
Due Dates: Rolling (internal vetting process)
Funding Amounts: Program-Related Investments (PRI); typical for seed-stage for-profit companies; amount not publicly specified.
Summary: Investment and support for early-stage companies developing impactful, evidence-based solutions to improve pediatric health.
Key Information: Funding is for for-profit, start-up companies with pediatric-focused solutions; not a traditional grant.
CH Innovations, a division of the Charles H. Hood Foundation, advances the foundation’s mission to improve the health and quality of life of children by making Program-Related Investments (PRIs) in early-stage, for-profit companies. The program targets companies developing innovative, high-impact solutions for child health, including diagnostic tools, medical devices, therapeutics, and healthcare IT. Investments are designed to bridge the gap between research and real-world application, supporting companies working on evidence-based interventions for pediatric patients (from birth through late adolescence). In addition to capital, CH Innovations portfolio companies gain access to a network of scientific, investment, and business development professionals to help accelerate product development and market adoption.